“One area of criminal enforcement that will be a focus for the Criminal Division in the months and years ahead [is the] application of the Foreign Corrupt Practices Act (FCPA) to the pharmaceutical industry. We will be vigilant in holding companies and individuals who break the law accountable, not only through civil actions ... but also by bringing criminal indictments if the facts and the laws warrant.” -- Lanny A. Breuer, DoJ Assistant Attorney General, Criminal Division, November 12, 2009.
Continue reading ""Pharma and Device Companies are the Next Target for FCPA Investigations"" »
